Media
Articles & insights
![](/images/15346dce-7153-490c-90bc-f2dc7b1b711d/Professor-Glen-Davison-presented-at-Global-Health-Summit-.jpg)
2 July 2024
Professor Glen Davison presented ColdZyme study at Global Health Summit
![](/images/dcc775f5-0519-40d1-82d6-6a2cf3692ca7/Claus-Egstrand---Global-Health.jpg)
5 April 2024
Enzymatica part of the Global Health Campaign
![](/images/f0fb489a-3cb1-4837-8d3e-39b921ddeae5/BJSM1.jpg)
18 March 2024
Abstract on clinical ColdZyme study published in British Journal of Sports Medicine
![](/images/0a4e21ec-9d5d-407b-ba54-3d2a5a14489d/OlympicGlen.jpg)
3 March 2024
Results from ColdZyme study presented at Olympic conference
![](/images/aa7ca9bd-bca7-47f4-bb87-68483c446c09/TBA.jpg)
8 January 2024
ColdZyme featured in the US morning show "The Balancing Act"
![](/images/f2fb3e5d-84e2-42a6-9fcc-fa1906c58676/xeckl526.png)
11 October 2023
ColdZyme reduces rhinovirus viral load and sore throat symptoms according to new study - interview with Professor Glen Davison
![](/images/3fc54635-068b-4f17-920e-20f4967306ad/interview-prof-doris-wilflingseder.jpg)
11 September 2023
ColdZyme breaks the viral infection cycle according to study - interview with Professor Doris Wilflingseder
![](/images/e260b4dd-d649-4dcd-8605-0a4e499e69e4/biostock-interview.png)
24 August 2023
Positive results from new study on influenza - CEO Claus Egstrand interviewed by BioStock
![](/images/303f3dfa-e700-471d-b712-1a99a6972a49/A-decade-of-ColdZyme-advertising.jpg)
13 July 2023
A decade of ColdZyme advertising
![](/images/ac620cc3-6e75-4e42-8594-8de1c6cb3653/Screenshot-Penser.png)
17 May 2023